• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实体瘤免疫治疗中的细胞外基质。

The extracellular matrix in solid tumor immunotherapy.

机构信息

Research Institute of Advanced Materials (RIAM), Seoul National University, Seoul, South Korea.

Research Institute of Advanced Materials (RIAM), Seoul National University, Seoul, South Korea; Department of Materials Science and Engineering, Institute of Engineering Research, BioMAX, Soft Foundry Institute, Seoul National University, Seoul, South Korea.

出版信息

Trends Immunol. 2024 Sep;45(9):705-714. doi: 10.1016/j.it.2024.07.009. Epub 2024 Aug 19.

DOI:10.1016/j.it.2024.07.009
PMID:39164157
Abstract

The extracellular matrix (ECM) of solid tumors impacts the antitumor activities of CD8 T and natural killer (NK) cells in a variety of ways. Cell motility is restricted by the tumor ECM which creates physical barriers. The tumor ECM directly alter the phenotypes and functions of cytotoxic lymphocytes, and indirectly influences immunological synapse-mediated interactions between cytotoxic lymphocytes and cancer cells. Therefore, strategies to improve solid tumor immunotherapy should be established by considering complex ternary interactions between cytotoxic lymphocytes, cancer cells, and the tumor ECM. Novel bioengineering tools approximating key characteristics of the tumor ECM, such as in vitro reconstituted 3D ECMs and microfluidics are valuable from a fundamental study viewpoint and from a translational perspective, aiming to enable systematic screening approaches.

摘要

肿瘤细胞外基质(ECM)以多种方式影响 CD8 T 细胞和自然杀伤(NK)细胞的抗肿瘤活性。细胞迁移受到肿瘤 ECM 的限制,它形成物理屏障。肿瘤 ECM 直接改变细胞毒性淋巴细胞的表型和功能,并间接影响细胞毒性淋巴细胞与癌细胞之间免疫突触介导的相互作用。因此,应该通过考虑细胞毒性淋巴细胞、癌细胞和肿瘤 ECM 之间的复杂三元相互作用来制定改善实体瘤免疫治疗的策略。模拟肿瘤 ECM 关键特征的新型生物工程工具,如体外重建的 3D ECM 和微流控技术,从基础研究的角度和转化的角度来看都是有价值的,旨在实现系统的筛选方法。

相似文献

1
The extracellular matrix in solid tumor immunotherapy.实体瘤免疫治疗中的细胞外基质。
Trends Immunol. 2024 Sep;45(9):705-714. doi: 10.1016/j.it.2024.07.009. Epub 2024 Aug 19.
2
Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy.肿瘤免疫调节中的细胞外基质动态变化:从肿瘤微环境到免疫治疗
J Hematol Oncol. 2025 Jun 19;18(1):65. doi: 10.1186/s13045-025-01717-y.
3
An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy.一种编码透明质酸酶的溶瘤痘苗病毒重塑细胞外基质,以增强癌症的化疗和免疫治疗效果。
J Immunother Cancer. 2024 Mar 7;12(3):e008431. doi: 10.1136/jitc-2023-008431.
4
Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin.氨通过降低成熟穿孔素水平来抑制自然杀伤细胞和T细胞的抗肿瘤活性。
Cancer Res. 2025 Jul 2;85(13):2448-2467. doi: 10.1158/0008-5472.CAN-24-0749.
5
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment.超越常规:肿瘤微环境中补体系统与细胞外基质之间新出现的相互作用
Semin Immunol. 2025 Mar;77:101929. doi: 10.1016/j.smim.2025.101929. Epub 2025 Jan 9.
6
Biomarkers of mRNA vaccine efficacy derived from mechanistic modeling of tumor-immune interactions.源自肿瘤免疫相互作用机制模型的mRNA疫苗疗效生物标志物。
PLoS Comput Biol. 2025 Jun 12;21(6):e1013163. doi: 10.1371/journal.pcbi.1013163. eCollection 2025 Jun.
7
Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review.自然杀伤细胞衍生的细胞外囊泡作为癌症有前途的免疫治疗策略:系统评价。
Int J Mol Sci. 2023 Feb 16;24(4):4026. doi: 10.3390/ijms24044026.
8
Cancer cell-derived extracellular vesicles: a potential target for overcoming tumor immunotherapy resistance and immune evasion strategies.癌细胞衍生的细胞外囊泡:克服肿瘤免疫治疗耐药性和免疫逃逸策略的潜在靶点。
Front Immunol. 2025 Jun 12;16:1601266. doi: 10.3389/fimmu.2025.1601266. eCollection 2025.
9
Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy.调节细胞外基质硬度:增强癌症免疫疗法的策略性方法。
Cell Death Dis. 2024 May 1;15(5):307. doi: 10.1038/s41419-024-06697-4.
10
Integrated single-cell and bulk sequencing analyses with experimental validation identify the prognostic and immunological implications of CD226 in pan-cancer.综合单细胞和批量测序分析并结合实验验证,鉴定了 CD226 在泛癌中的预后和免疫意义。
J Cancer Res Clin Oncol. 2023 Nov;149(16):14597-14617. doi: 10.1007/s00432-023-05268-y. Epub 2023 Aug 14.

引用本文的文献

1
Enhancing the potency of CAR-T cells against solid tumors through transcription factor engineering.通过转录因子工程增强嵌合抗原受体T细胞(CAR-T)对实体瘤的效力。
JCI Insight. 2025 Jul 22;10(14). doi: 10.1172/jci.insight.193048.
2
CAR-T cell therapy in brain malignancies: obstacles in the face of cellular trafficking and persistence.嵌合抗原受体T细胞疗法在脑恶性肿瘤中的应用:细胞转运与存活面临的障碍
Front Immunol. 2025 Jun 19;16:1596499. doi: 10.3389/fimmu.2025.1596499. eCollection 2025.
3
Natural killer cell membrane manipulation for augmented immune synapse and anticancer efficacy.
用于增强免疫突触和抗癌疗效的自然杀伤细胞膜操作
Mater Today Bio. 2025 Jun 9;33:101965. doi: 10.1016/j.mtbio.2025.101965. eCollection 2025 Aug.
4
NK cell activity in the tumor microenvironment.肿瘤微环境中的自然杀伤细胞活性。
Front Cell Dev Biol. 2025 May 30;13:1609479. doi: 10.3389/fcell.2025.1609479. eCollection 2025.
5
A self-directed Trojanbot-enzymatic nanobot in neutrobot for active target therapy of glioblastoma.一种用于胶质母细胞瘤主动靶向治疗的自导向特洛伊机器人酶纳米机器人,存在于中性机器人中。
Nat Commun. 2025 Jun 6;16(1):5263. doi: 10.1038/s41467-025-60422-z.
6
Inhibits the Growth of Hepatocellular Carcinoma Cells via Cross-Species Regulation of .通过. 的种间调控抑制肝癌细胞的生长。
Genes (Basel). 2024 Sep 4;15(9):1165. doi: 10.3390/genes15091165.